[1]
M. I. Shved and R. M. Ovsiichuk, “EFFECTIVENESS OF DYSLIPIDEMIA AND PRO-OXIDANT-ANTIOXIDANT BALANCE CORRECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME ON THE BACKGROUND OF TYPE 2 DIABETES WITH SGLT2 INHIBITOR – DAPAGLIFLOZIN”, MCCh, no. 3, pp. 18–26, Dec. 2022.